Impact of Hospitalization on Sarcopenia, NADPH-Oxidase 2, Oxidative Stress, and Low-Grade Endotoxemia in Elderly Patients
Abstract
:1. Introduction
2. Materials and Methods
2.1. sNOX2-dp Assay
2.2. Hydrogen Peroxide (H2O2) Production
2.3. Serum Zonulin
2.4. Serum LPS Assay
2.5. Sample Size Determination
2.6. Statistical Analysis
3. Results
4. Discussion
5. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Acknowledgments
Conflicts of Interest
References
- Larsson, L.; Degens, H.; Li, M.; Salviati, L.; Lee, Y.I.; Thompson, W.; Kirkland, J.L.; Sandri, M. Sarcopenia: Aging-Related Loss of Muscle Mass and Function. Physiol. Rev. 2019, 99, 427–511. [Google Scholar] [CrossRef]
- Beaudart, C.; McCloskey, E.; Bruyere, O.; Cesari, M.; Rolland, Y.; Rizzoli, R.; Araujo de Carvalho, I.; Amuthavalli Thiyagarajan, J.; Bautmans, I.; Bertiere, M.C.; et al. Sarcopenia in daily practice: Assessment and management. BMC Geriatr. 2016, 16, 170. [Google Scholar] [CrossRef] [PubMed]
- Nijholt, W.; Scafoglieri, A.; Jager-Wittenaar, H.; Hobbelen, J.S.M.; van der Schans, C.P. The reliability and validity of ultrasound to quantify muscles in older adults: A systematic review. J. Cachexia Sarcopenia Muscle 2017, 8, 702–712. [Google Scholar] [CrossRef] [PubMed]
- Dhillon, R.J.; Hasni, S. Pathogenesis and Management of Sarcopenia. Clin. Geriatr. Med. 2017, 33, 17–26. [Google Scholar] [CrossRef]
- Wang, M.; Ren, F.; Zhou, Y.; He, Y.; Du, T.; Tan, Y. Age-related sarcopenia and altered gut microbiota: A systematic review. Microb. Pathog. 2024, 195, 106850. [Google Scholar] [CrossRef] [PubMed]
- Damiano, S.; Muscariello, E.; La Rosa, G.; Di Maro, M.; Mondola, P.; Santillo, M. Dual Role of Reactive Oxygen Species in Muscle Function: Can Antioxidant Dietary Supplements Counteract Age-Related Sarcopenia? Int. J. Mol. Sci. 2019, 20, 3815. [Google Scholar] [CrossRef]
- Weindruch, R. Interventions based on the possibility that oxidative stress contributes to sarcopenia. J. Gerontol. A Biol. Sci. Med. Sci. 1995, 50, 157–161. [Google Scholar] [CrossRef]
- Deldicque, L. Endoplasmic reticulum stress in human skeletal muscle: Any contribution to sarcopenia? Front. Physiol. 2013, 4, 236. [Google Scholar] [CrossRef]
- Zhang, H.; Qi, G.; Wang, K.; Yang, J.; Shen, Y.; Yang, X.; Chen, X.; Yao, X.; Gu, X.; Qi, L.; et al. Oxidative stress: Roles in skeletal muscle atrophy. Biochem. Pharmacol. 2023, 214, 115664. [Google Scholar] [CrossRef]
- Liu, C.; Cheung, W.H.; Li, J.; Chow, S.K.; Yu, J.; Wong, S.H.; Ip, M.; Sung, J.J.Y.; Wong, R.M.Y. Understanding the gut microbiota and sarcopenia: A systematic review. J. Cachexia Sarcopenia Muscle 2021, 12, 1393–1407. [Google Scholar] [CrossRef]
- Loffredo, L.; Ettorre, E.; Zicari, A.M.; Inghilleri, M.; Nocella, C.; Perri, L.; Spalice, A.; Fossati, C.; De Lucia, M.C.; Pigozzi, F.; et al. Oxidative Stress and Gut-Derived Lipopolysaccharides in Neurodegenerative Disease: Role of NOX2. Oxid. Med. Cell. Longev. 2020, 2020, 8630275. [Google Scholar] [CrossRef] [PubMed]
- De Spiegeleer, A.; Elewaut, D.; Van Den Noortgate, N.; Janssens, Y.; Debunne, N.; Van Langenhove, S.; Govindarajan, S.; De Spiegeleer, B.; Wynendaele, E. Quorum sensing molecules as a novel microbial factor impacting muscle cells. Biochim. Biophys. Acta Mol. Basis Dis. 2020, 1866, 165646. [Google Scholar] [CrossRef]
- Song, J.; Wang, C.; Long, D.; Li, Z.; You, L.; Brand-Saberi, B.; Wang, G.; Yang, X. Dysbacteriosis-induced LPS elevation disturbs the development of muscle progenitor cells by interfering with retinoic acid signaling. FASEB J. 2020, 34, 6837–6853. [Google Scholar] [CrossRef] [PubMed]
- Ghosh, S.; Lertwattanarak, R.; Garduno Jde, J.; Galeana, J.J.; Li, J.; Zamarripa, F.; Lancaster, J.L.; Mohan, S.; Hussey, S.; Musi, N. Elevated muscle TLR4 expression and metabolic endotoxemia in human aging. J. Gerontol. A Biol. Sci. Med. Sci. 2015, 70, 232–246. [Google Scholar] [CrossRef] [PubMed]
- Espinosa, A.; Henriquez-Olguin, C.; Jaimovich, E. Reactive oxygen species and calcium signals in skeletal muscle: A crosstalk involved in both normal signaling and disease. Cell Calcium 2016, 60, 172–179. [Google Scholar] [CrossRef]
- Violi, F.; Cammisotto, V.; Bartimoccia, S.; Pignatelli, P.; Carnevale, R.; Nocella, C. Gut-derived low-grade endotoxaemia, atherothrombosis and cardiovascular disease. Nat. Rev. Cardiol. 2023, 20, 24–37. [Google Scholar] [CrossRef]
- Bortz, W.M., 2nd. A conceptual framework of frailty: A review. J. Gerontol. A Biol. Sci. Med. Sci. 2002, 57, M283–M288. [Google Scholar] [CrossRef]
- Chang, B.P. Can hospitalization be hazardous to your health? A nosocomial based stress model for hospitalization. Gen. Hosp. Psychiatry 2019, 60, 83–89. [Google Scholar] [CrossRef]
- Ciacci, P.; Paraninfi, A.; Orlando, F.; Rella, S.; Maggio, E.; Oliva, A.; Cangemi, R.; Carnevale, R.; Bartimoccia, S.; Cammisotto, V.; et al. Endothelial dysfunction, oxidative stress and low-grade endotoxemia in COVID-19 patients hospitalised in medical wards. Microvasc. Res. 2023, 149, 104557. [Google Scholar] [CrossRef]
- Sasaki, K.I.; Fukumoto, Y. Sarcopenia as a comorbidity of cardiovascular disease. J. Cardiol. 2022, 79, 596–604. [Google Scholar] [CrossRef]
- Malmstrom, T.K.; Morley, J.E. Sarcopenia: The Target Population. J. Frailty Aging 2013, 2, 55–56. [Google Scholar] [CrossRef] [PubMed]
- Mehmet, H.; Yang, A.W.H.; Robinson, S.R. Measurement of hand grip strength in the elderly: A scoping review with recommendations. J. Bodyw. Mov. Ther. 2020, 24, 235–243. [Google Scholar] [CrossRef]
- Mahoney, F.I.; Barthel, D.W. Functional Evaluation: The Barthel Index. Md. State Med. J. 1965, 14, 61–65. [Google Scholar] [PubMed]
- Rubenstein, L.Z.; Harker, J.O.; Salva, A.; Guigoz, Y.; Vellas, B. Screening for undernutrition in geriatric practice: Developing the short-form mini-nutritional assessment (MNA-SF). J. Gerontol. A Biol. Sci. Med. Sci. 2001, 56, M366–M372. [Google Scholar] [CrossRef] [PubMed]
- Folstein, M.F.; Folstein, S.E.; McHugh, P.R. “Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician. J. Psychiatr. Res. 1975, 12, 189–198. [Google Scholar] [CrossRef]
- Yesavage, J.A.; Brink, T.L.; Rose, T.L.; Lum, O.; Huang, V.; Adey, M.; Leirer, V.O. Development and validation of a geriatric depression screening scale: A preliminary report. J. Psychiatr. Res. 1982, 17, 37–49. [Google Scholar] [CrossRef]
- Linn, B.S.; Linn, M.W.; Gurel, L. Cumulative illness rating scale. J. Am. Geriatr. Soc. 1968, 16, 622–626. [Google Scholar] [CrossRef]
- Miller, M.D.; Paradis, C.F.; Houck, P.R.; Mazumdar, S.; Stack, J.A.; Rifai, A.H.; Mulsant, B.; Reynolds, C.F., 3rd. Rating chronic medical illness burden in geropsychiatric practice and research: Application of the Cumulative Illness Rating Scale. Psychiatry Res. 1992, 41, 237–248. [Google Scholar] [CrossRef]
- Rustani, K.; Kundisova, L.; Capecchi, P.L.; Nante, N.; Bicchi, M. Ultrasound measurement of rectus femoris muscle thickness as a quick screening test for sarcopenia assessment. Arch. Gerontol. Geriatr. 2019, 83, 151–154. [Google Scholar] [CrossRef]
- Wallbridge, P.; Parry, S.M.; Das, S.; Law, C.; Hammerschlag, G.; Irving, L.; Hew, M.; Steinfort, D. Parasternal intercostal muscle ultrasound in chronic obstructive pulmonary disease correlates with spirometric severity. Sci. Rep. 2018, 8, 15274. [Google Scholar] [CrossRef]
- Barbosa-Silva, T.G.; Menezes, A.M.; Bielemann, R.M.; Malmstrom, T.K.; Gonzalez, M.C.; Grupo de Estudos em Composição Corporal e Nutrição (COCONUT). Enhancing SARC-F: Improving Sarcopenia Screening in the Clinical Practice. J. Am. Med. Dir. Assoc. 2016, 17, 1136–1141. [Google Scholar] [CrossRef] [PubMed]
- Strini, V.; Piazzetta, N.; Gallo, A.; Schiavolin, R. Barthel Index: Creation and validation of two cut-offs using the BRASS Index. Acta Biomed. 2020, 91, 19–26. [Google Scholar] [CrossRef]
- Vellas, B.; Guigoz, Y.; Garry, P.J.; Nourhashemi, F.; Bennahum, D.; Lauque, S.; Albarede, J.L. The Mini Nutritional Assessment (MNA) and its use in grading the nutritional state of elderly patients. Nutrition 1999, 15, 116–122. [Google Scholar] [CrossRef]
- Cardoso, S.; Barros, R.; Maroco, J.; de Mendonca, A.; Guerreiro, M. Different MMSE domains are associated to cognitive decline and education. Appl. Neuropsychol. Adult 2024, 31, 533–539. [Google Scholar] [CrossRef]
- Waldman, E.; Potter, J.F. A prospective evaluation of the cumulative illness rating scale. Aging 1992, 4, 171–178. [Google Scholar] [CrossRef]
- Carnevale, R.; Silvestri, R.; Loffredo, L.; Novo, M.; Cammisotto, V.; Castellani, V.; Bartimoccia, S.; Nocella, C.; Violi, F. Oleuropein, a component of extra virgin olive oil, lowers postprandial glycaemia in healthy subjects. Br. J. Clin. Pharmacol. 2018, 84, 1566–1574. [Google Scholar] [CrossRef] [PubMed]
- Coker, R.H.; Wolfe, R.R. Bedrest and sarcopenia. Curr. Opin. Clin. Nutr. Metab. Care 2012, 15, 7–11. [Google Scholar] [CrossRef]
- Surkan, M.J.; Gibson, W. Interventions to Mobilize Elderly Patients and Reduce Length of Hospital Stay. Can. J. Cardiol. 2018, 34, 881–888. [Google Scholar] [CrossRef] [PubMed]
- Sousa, A.S.; Guerra, R.S.; Fonseca, I.; Pichel, F.; Ferreira, S.; Amaral, T.F. Financial impact of sarcopenia on hospitalization costs. Eur. J. Clin. Nutr. 2016, 70, 1046–1051. [Google Scholar] [CrossRef]
- Henriquez-Olguin, C.; Boronat, S.; Cabello-Verrugio, C.; Jaimovich, E.; Hidalgo, E.; Jensen, T.E. The Emerging Roles of Nicotinamide Adenine Dinucleotide Phosphate Oxidase 2 in Skeletal Muscle Redox Signaling and Metabolism. Antioxid. Redox Signal. 2019, 31, 1371–1410. [Google Scholar] [CrossRef]
- Henriquez-Olguin, C.; Meneses-Valdes, R.; Raun, S.H.; Gallero, S.; Knudsen, J.R.; Li, Z.; Li, J.; Sylow, L.; Jaimovich, E.; Jensen, T.E. NOX2 deficiency exacerbates diet-induced obesity and impairs molecular training adaptations in skeletal muscle. Redox Biol. 2023, 65, 102842. [Google Scholar] [CrossRef]
- Jang, J.Y.; Kim, D.; Kim, N.D. Pathogenesis, Intervention, and Current Status of Drug Development for Sarcopenia: A Review. Biomedicines 2023, 11, 1635. [Google Scholar] [CrossRef] [PubMed]
- Boehme, M.; Guzzetta, K.E.; Wasen, C.; Cox, L.M. The gut microbiota is an emerging target for improving brain health during ageing. Gut Microbiome 2023, 4, e2. [Google Scholar] [CrossRef] [PubMed]
- Qi, Y.; Goel, R.; Kim, S.; Richards, E.M.; Carter, C.S.; Pepine, C.J.; Raizada, M.K.; Buford, T.W. Intestinal Permeability Biomarker Zonulin is Elevated in Healthy Aging. J. Am. Med. Dir. Assoc. 2017, 18, 810.e1–810.e4. [Google Scholar] [CrossRef] [PubMed]
- Wakabayashi, H. Hospital-associated sarcopenia, acute sarcopenia, and iatrogenic sarcopenia: Prevention of sarcopenia during hospitalization. J. Gen. Fam. Med. 2023, 24, 146–147. [Google Scholar] [CrossRef]
- Pannunzio, A.; Baratta, F.; Maggio, E.; Palumbo, I.M.; Magna, A.; Trivigno, C.; Carnevale, R.; Simona, B.; Cammisotto, V.; Vidili, G.; et al. Dark chocolate’s impact on low-grade endotoxemia in metabolic dysfunction-associated steatohepatitis. Nutrition 2024, 131, 112643. [Google Scholar] [CrossRef]
- Di Lorito, C.; Long, A.; Byrne, A.; Harwood, R.H.; Gladman, J.R.F.; Schneider, S.; Logan, P.; Bosco, A.; van der Wardt, V. Exercise interventions for older adults: A systematic review of meta-analyses. J. Sport Health Sci. 2021, 10, 29–47. [Google Scholar] [CrossRef]
- Bolliger, M.F.; Zurlinden, A.; Luscher, D.; Butikofer, L.; Shakhova, O.; Francolini, M.; Kozlov, S.V.; Cinelli, P.; Stephan, A.; Kistler, A.D.; et al. Specific proteolytic cleavage of agrin regulates maturation of the neuromuscular junction. J. Cell Sci. 2010, 123, 3944–3955. [Google Scholar] [CrossRef]
- Papadopoulou, S.K.; Papadimitriou, K.; Voulgaridou, G.; Georgaki, E.; Tsotidou, E.; Zantidou, O.; Papandreou, D. Exercise and Nutrition Impact on Osteoporosis and Sarcopenia-The Incidence of Osteosarcopenia: A Narrative Review. Nutrients 2021, 13, 4499. [Google Scholar] [CrossRef]
Clinical Characteristics | Outpatients (n = 31) | Hospitalized Patients (n = 31) | p-Value |
---|---|---|---|
Age (years) | 80 ± 4 | 82 ± 8 | p = 0.210 |
Gender males/females | 14/17 | 14/17 | p = 1 |
NOX2 (pg/mL) | 9.4 ± 5.6 | 20.9 ± 6.5 | p < 0.001 |
Zonulin (ng/mL) | 1.5 ± 0.43 | 2.06 ± 1.23 | p = 0.007 |
LPS (pg/mL) | 11.2 ± 3.2 | 30.4 ± 12.6 | p < 0.001 |
H2O2 µM | 9.3 ± 3.04 | 24.4 ± 9.8 | p < 0.001 |
MMSE | 27.7 ± 1.3 | 19.3 ± 9.9 | p < 0.001 |
Barthel | 89.8 ± 5.6 | 45.6 ± 34.4 | p < 0.001 |
Arterial Hypertension yes/no | 23/8 | 22/9 | p = 0.745 |
Diabetes Mellitus yes/no | 3/28 | 14/17 | p < 0.001 |
Dyslipidaemia yes/no | 13/18 | 21/10 | p = 0.020 |
Heart Failure yes/no | 0/31 | 10/21 | p < 0.001 |
Former Smokers yes/no | 0/31 | 13/18 | p < 0.001 |
Dementia yes/no | 0/31 | 15/16 | p < 0.001 |
BMI | 24.6 ± 2.4 | 21.8 ± 3.17 | p < 0.001 |
Days of hospitalization | - | 14.4 ± 8.1 | p < 0.001 |
Antibiotic therapy yes/no | 0/31 | 19/12 | p < 0.001 |
Statin therapy yes/no | 13/18 | 20/11 | p < 0.001 |
Anticoagulant therapy yes/no | 0/31 | 20/11 | p < 0.001 |
Antiplatelet therapy yes/no | 0/31 | 20/11 | p < 0.001 |
Pneumonia yes/no | 0/31 | 19/12 | p < 0.001 |
Anemia yes/no | 0/31 | 14/17 | p < 0.001 |
Chronic Ischaemic Heart disease yes/no | 0/31 | 17/14 | p < 0.001 |
Previous Venous Thromboembolism yes/no | 0/31 | 0/31 | p < 0.001 |
Triglycerides mg/dL | 99 ± 37 | 73.9 ± 19 | p < 0.001 |
Total cholesterol mg/dL | 131 ± 44.6 | 144 ± 27 | p < 0.001 |
Assessment | Admission | Discharge | p-Value |
---|---|---|---|
Barthel Scale | 45.6 ± 34.4 | 33.8 ± 31.6 | p < 0.001 |
Rectus femoris (RF) muscle thickness cm | 0.5 ± 0.29 | 0.3 ± 0.31 | p < 0.001 |
MMSE | 19.3 ± 9.9 | 17.7 ± 10 | p < 0.001 |
GDS | 6.6 ±2.7 | 9.4 ± 2.6 | p < 0.001 |
CIRS | 18.4 ± 10.4 | 22 ± 10.2 | p < 0.001 |
MNA | 17.1 ± 3.6 | 13.1 ± 2.3 | p < 0.001 |
Hand grip test | 13.4 ± 10.8 | 10.0 ± 8.2 | p < 0.001 |
SARC-F | 5.01 ± 1.16 | 7.6 ± 0.78 | p < 0.001 |
Intercostal muscle thickness cm | 0.22 ± 0.08 | 0.16 ± 0.06 | p < 0.001 |
Diaphragmatic muscle thickness cm | 0.19 ± 0.06 | 0.14 ± 0.04 | p < 0.001 |
sNOX2-dp (pg/mL) | 20.9 ± 6.5 | 23.8 ± 7.5 | p = 0.004 |
H2O2 µM | 24.4 ± 9.8 | 32.8 ± 14.5 | p = 0.01 |
LPS pg/ml | 30.4 ± 12.6 | 43.3 ± 16.35 | p < 0.001 |
Zonulin (ng/mL) | 2.06 ± 1.23 | 2.95 ± 1.33 | p < 0.001 |
Leg circumference cm | 36.06 ± 5.3 | 31.48 ± 2.5 | p < 0.001 |
Arm circumference cm | 24.90 ± 2.9 | 21.29 ± 1.9 | p < 0.001 |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2025 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Bagnato, C.; Magna, A.; Mereu, E.; Bernardini, S.; Bartimoccia, S.; Marti, R.; Lazzerini, P.E.; D’Amico, A.; Ettorre, E.; Desideri, G.; et al. Impact of Hospitalization on Sarcopenia, NADPH-Oxidase 2, Oxidative Stress, and Low-Grade Endotoxemia in Elderly Patients. Antioxidants 2025, 14, 304. https://doi.org/10.3390/antiox14030304
Bagnato C, Magna A, Mereu E, Bernardini S, Bartimoccia S, Marti R, Lazzerini PE, D’Amico A, Ettorre E, Desideri G, et al. Impact of Hospitalization on Sarcopenia, NADPH-Oxidase 2, Oxidative Stress, and Low-Grade Endotoxemia in Elderly Patients. Antioxidants. 2025; 14(3):304. https://doi.org/10.3390/antiox14030304
Chicago/Turabian StyleBagnato, Chiara, Arianna Magna, Elena Mereu, Sciaila Bernardini, Simona Bartimoccia, Roberta Marti, Pietro Enea Lazzerini, Alessandra D’Amico, Evaristo Ettorre, Giovambattista Desideri, and et al. 2025. "Impact of Hospitalization on Sarcopenia, NADPH-Oxidase 2, Oxidative Stress, and Low-Grade Endotoxemia in Elderly Patients" Antioxidants 14, no. 3: 304. https://doi.org/10.3390/antiox14030304
APA StyleBagnato, C., Magna, A., Mereu, E., Bernardini, S., Bartimoccia, S., Marti, R., Lazzerini, P. E., D’Amico, A., Ettorre, E., Desideri, G., Pignatelli, P., Violi, F., Carnevale, R., Loffredo, L., & Neurodegenerative Study Group. (2025). Impact of Hospitalization on Sarcopenia, NADPH-Oxidase 2, Oxidative Stress, and Low-Grade Endotoxemia in Elderly Patients. Antioxidants, 14(3), 304. https://doi.org/10.3390/antiox14030304